{
  "Variants Include": [
    {
      "Gene": "ATM",
      "variants": [
        {
          "HGVS": "NM_000051.6:c.6708G>A",
          "cDNA Change": {
            "transcript": "NM_000051.6",
            "ref": "G",
            "alt": "A",
            "position": "6708"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "D",
            "position": "2237"
          },
          "Description in input context": "c.6708G>A (p.G2237D)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Ataxia-telangiectasia",
    "MONDO": "MONDO:0001584"
  },
  "Experiment Method": [
    {
      "Assay Method": "Immunoblotting",
      "Material used": {
        "Material Source": "Primary cells",
        "Material Name": "Human Ataxia-telangiectasia fibroblasts",
        "Description": "The experiment was performed using primary human Ataxia-telangiectasia fibroblasts."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000051.6:c.6708G>A",
          "Conclusion": "Intermediate effect",
          "Molecular Effect": "intermediate effect",
          "Result Description": "For the variant NM_000051.6:c.6708G>A, the protein expression level was found to be 75%."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Healthy individual's fibroblasts were used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "No",
        "Description": "No negative control was included in this experiment."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Description": "No validation controls were included for benign variants."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "T-test was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression level greater than 90%.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression level less than 50%.",
        "Source": "Custom (as no threshold is specified in the literature)"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}